子類別 期刊論文 [27/27] 會議論文/會議摘要 [5/7] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [104/107] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡慧珍 [67/72] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [444/511] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [465/472] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:2(5.88%) 含全文筆數:32(94.12%) 文件下載次數統計 下載大於0次:32(100.00%) 下載大於100次:31(96.88%) 檔案下載總次數:14088(0.25%) 最後更新時間: 2024-12-12 03:24 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Oncogenic ASPM is a regulatory hub ... ASPM activates Hedgehog and Wnt sig... A Novel Invadopodia-Specific Marker... A novel invadopodia-specific marker... A multi-mode Wnt- and stemness-regu... A multi-mode Wnt- and stemness-regu... Dishevelled 1-regulated superpotent... A multicenter, phase I/II trial of ... Histone demethylase KDM4C stimulate... The differential distributions of A...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 34. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2023-09-15	Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers	Cancer Research. 2023 Sep 15;83(18):2993-3000.
2023-03	ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression	Cancer Research. 2023 Mar 15;83(6):830-844.
2021-06-22	A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]	Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
2021-05-31	A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells	Frontiers in Oncology. 2021 May 31;11:Article number 638311.
2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	Gastric Cancer. 2021 May;24(3):624-639.
2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.]	Gastric Cancer. 2021 May;24(3):640-641.
2020-03-10	Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma	Stem Cell Reports. 2020 Mar 10;14(3):462-477.
2020-02	The multifaceted role of mesenchymal stem cells in cancer	Seminars in Cancer Biology. 2020 Feb;60:225-237.
2020-01	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	European Journal of Cancer. 2020 Jan;124:123-130.
2019-12	The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis	Journal of Pathology. 2019 Dec;249(4):498-508.
2019-11-13	Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc	Cancers. 2019 Nov 13;11(11):Article number 1785.
2019-07	Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers	Frontiers in Oncology. 2019 Jul;9:Article number 688.
2019-05-17	Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks	Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	Oncogene. 2019 Feb;38(8):1340-1353.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]	Oncogene. 2019 Feb;38(8):1354.
2018-12	ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness	Cancer Science. 2018 Dec;109(Suppl. 2):244.
2018-11	Targeting PTX3 can prevent drug-resistant cancer progression	Protein Science. 2018 Nov;27(Suppl. 1):24.
2018-10	Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
2017-11	Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma	Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
2017-05	Metronomic chemotherapy: Direct targeting of cancer cells after all?	Trends in Cancer. 2017 May;3(5):319-325.
2016-12	Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells	Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988.
2016-12	NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme	Molecular Biology of the Cell. 2016 Dec;27:Meeting Abstract P1160.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2015-11	Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers	Annals of Oncology. 2015 Nov;26:vii106-vii151.
2015-09	Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers	Oncotarget. 2015 Sep;6(27):23987-24001.

顯示項目1-25 / 34. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目